Baker Bros. Advisors Lp
Affiliations
- Insider at Kodiak Sciences Inc. (KOD), 2026-07-02
- Insider at Incyte Corp (INCY), 2026-07-02
- Insider at Vtv Therapeutics Inc. (VTVT), 2026-06-29
- Insider at Kymera Therapeutics Inc. (KYMR), 2026-06-25
- Insider at Madrigal Pharmaceuticals Inc. (MDGL), 2026-06-18
- Insider at Beone Medicines Ltd. (ONC), 2026-06-15
- Insider at Prelude Therapeutics Inc (PRLD), 2026-06-10
- Insider at Denali Therapeutics Inc. (DNLI), 2026-06-05
- Insider at Acadia Pharmaceuticals Inc (ACAD), 2026-06-02
- Insider at Kiniksa Pharmaceuticals International Plc (KNSA), 2026-06-02
- Insider at Tscan Therapeutics Inc. (TCRX), 2026-05-22
- Insider at Replimune Group Inc. (REPL), 2026-04-08
- Insider at Dbv Technologies S.a. (DBVT), 2026-01-14
- Insider at Bicycle Therapeutics Plc (BCYC), 2026-01-06
- Insider at Entrada Therapeutics Inc. (TRDA), 2025-11-24
- Insider at Kala Bio Inc. (KALA), 2025-10-02
- Insider at Celcuity Inc. (CELC), 2025-09-10
- Insider at Igm Biosciences Inc. (IGMS), 2025-08-18
- Insider at Immunocore Holdings Plc (IMCR), 2025-05-19
- Insider at Sera Prognostics Inc. (SERA), 2025-02-14
- Director, Other at Neurogene Inc. (NGNE), 2023-12-20
- Director, Other at Seagen Inc. (SGEN), 2023-12-18
- Large Shareholder at Bellicum Pharmaceuticals Inc (BLCM), 2023-11-24
- Other at Atreca Inc. (BCEL), 2023-10-23
- Large Shareholder, Director at Talis Biomedical Corp (TLIS), 2023-06-13
- Director at Aeglea Biotherapeutics Inc. (AGLE), 2021-06-10
- Director at Alexion Pharmaceuticals Inc. (ALXN), 2020-05-18
- Director at Zymeworks Inc. (ZYME), 2020-05-12
- Large Shareholder, Director at Genomic Health Inc (GHDX), 2019-10-03
- Large Shareholder at Idera Pharmaceuticals Inc. (IDRA), 2019-07-03
- Other at Hookipa Pharma Inc. (HOOK), 2019-04-23
- Large Shareholder at Principia Biopharma Inc. (PRNB), 2018-09-13
- Large Shareholder at Invitae Corp (NVTA), 2018-03-29
- Other at Mirati Therapeutics Inc. (MRTX), 2017-11-20
- Other at Rhythm Pharmaceuticals Inc. (RYTM), 2017-10-06
- Large Shareholder at Biocryst Pharmaceuticals Inc (BCRX), 2016-08-16
- Other at Intellia Therapeutics Inc. (NTLA), 2016-05-11
- Other at Xoma Corp (XOMA), 2015-07-23
- Other at Synageva Biopharma Corp (GEVA), 2015-06-23
- Large Shareholder, Director at Ardea Biosciences Inc. (RDEA), 2012-06-21
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| KOD | $23.00 | 2,391,268 | $54,999,164.00 | 18,358,772 | 2025-12-18 | Filing |
| KOD | $23.00 | 217,428 | $5,000,844.00 | 1,560,414 | 2025-12-18 | Filing |
| KYMR | $86.00 | 1,838,621 | $158,121,406.00 | 7,955,916 | 2025-12-11 | Filing |
| KYMR | $86.00 | 167,192 | $14,378,512.00 | 701,326 | 2025-12-11 | Filing |
| TRDA | $9.07 | 13,082 | $118,690.37 | 4,691,392 | 2025-11-20 | Filing |
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| ONC | $23.79 | 2,756 | $65,566.62 | 142,570 | 2026-05-22 | Filing |
| ONC | $23.79 | 2,756 | $65,566.62 | 142,566 | 2026-05-22 | Filing |
| ONC | $23.85 | 2,743 | $65,423.84 | 145,326 | 2026-05-22 | Filing |
| ONC | $23.85 | 2,743 | $65,423.84 | 145,322 | 2026-05-22 | Filing |
| KALA | $1.38 | 462,967 | $640,653.73 | 425,006 | 2025-10-01 | Filing |